tDCS in the Management of Post-COVID Disorders
Unknown statusPhase 2NCT06074848
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Different physical and mental morbidities such as pain, fatigue, depressed mood and cognitive impairment can be triggered by coronavirus infection. Transcranial direct current stimulation (tDCS), an easy-to-apply, non-pharmacological and safe technique, has been used to attenuate these symptoms caused by other diseases, and, therefore, it is expected that it can also attenuate them when generated by COVID-19. It is known that the persistent inflammatory state observed after COVID-19 would be related to the progression of these negative symptoms. As non-invasive brain stimulation can also attenuate acute and persistent inflammation, it can be estimated that tDCS can be a useful tool to recover immune function and reduce post-COVID-19 morbidity.
Study details
- Official title
- Transcranial Direct Current Stimulation as a Strategy for the Management of Disorders Generated by COVID-19: a Multicentric Study.
- Conditions
- Interventions
- Device: Transcranial Direct Current Stimulation (tDCS)
- Behavioral: Motor Training
- Behavioral: Cognitive Training
- Sponsor
- Universidade Federal de Pernambuco
- Collaborators
- São Paulo State University
- Start date
- 2023-08-25
- Primary completion
- 2024-07-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Brazil
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Long COVID-19 (\>3 months) * The presence of at least one of the following symptoms, after diagnosed SARS-COV-2 infection: Persistent pain Fatigue Depressed mood Cognitive impairment Exclusion Criteria: * Hemodynamic instability * Historic of use or abuse of drugs or alcohol * Use of medications that may interfere with the study results (anti-inflammatories and antibiotics) * Metallic implant in skull and face * Implant in the central nervous system * Pacemaker
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06074848